panipenem-betamipron has been researched along with cephalosporin c in 2 studies
| Studies (panipenem-betamipron) | Trials (panipenem-betamipron) | Recent Studies (post-2010) (panipenem-betamipron) | Studies (cephalosporin c) | Trials (cephalosporin c) | Recent Studies (post-2010) (cephalosporin c) |
|---|---|---|---|---|---|
| 68 | 17 | 7 | 20,476 | 2,093 | 4,152 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Fukuoka, T; Inoue, H; Ohya, S | 1 |
| Abe, T; Fukuoka, T; Ito, K; Sato, Y; Sei, M | 1 |
2 other study(ies) available for panipenem-betamipron and cephalosporin c
| Article | Year |
|---|---|
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2001 |
[Antibacterial activity of panipenem against clinical isolates in 2000 and 2001].
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; beta-Alanine; Carbapenems; Cephalosporins; Child; Dosage Forms; Drug Resistance, Bacterial; Humans; Japan; Microbial Sensitivity Tests; Product Surveillance, Postmarketing; Thienamycins; Time Factors | 2002 |